Skip to Main Content

Paper Details

Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles.
Arthritis Rheumatol
14
2022
APCAs, CCP2, CCP3, CMV-IgG antibody, EA-IgA, EA-IgG, EA-IgG antibody, EBNA-1-IgG, EBV, Epstein-Barr Virus, Epstein-Barr virus, IgG antibodies, Patients, RA, RF, RF-IgA, RF-IgG, RF-IgM, RF-neph, Rheumatoid Arthritis, VCA-IgA, VCA-IgG, anti-, rheumatoid arthritis
Author NameAffiliation
John B HarleyDepartment of Veterans Affairs Medical Center
William H RobinsonStanford University School of Medicine
  • 1 - 2

Datasets

Release 1.2